Characterization of the circadian system in binge eating disorder and the effects of morning bright light and individually timed exogenous melatonin administration: A 4-week feasibility double-blind randomized controlled mechanistic clinical trial
This study found that while a delayed circadian phase correlates with greater binge eating disorder severity and dampened activity rhythms, a 4-week feasibility trial combining morning bright light with individually timed melatonin was well-tolerated but did not significantly shift circadian phase, suggesting the need for further refinement of this chronobiotic intervention.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
For many people, the body operates on a reliable internal clock that dictates when to feel awake, when to feel tired, and when to feel hungry. This system, known as the circadian rhythm, is not just about sleep; it organizes metabolism, hormone release, and behavior throughout the day and night. When this clock gets out of sync, it can disrupt how the body processes food and regulates appetite. In recent years, scientists have noticed that people with binge eating disorder—a condition defined by recurrent episodes of consuming large amounts of food with a sense of losing control—often exhibit patterns that suggest their internal clocks are misaligned. These individuals frequently report stronger cravings later in the day and a tendency to eat more at night. The question researchers have been asking is whether this disorder is linked to a specific shift in the body's biological timing, and if adjusting that timing could help manage the condition.
A team of researchers set out to investigate this connection through a two-part study involving adults with obesity. In the first phase, they compared the biological rhythms of people with binge eating disorder to those without the disorder. They measured the exact moment each person's body began to produce melatonin, a hormone that signals the onset of night, using a method that involved collecting saliva samples at regular intervals in dim light. They also tracked the participants' movement and activity levels over two weeks using wrist-worn devices. The researchers found that, on average, the timing of the melatonin release was not significantly different between the two groups. However, a closer look revealed a meaningful pattern: within the group with binge eating disorder, those whose internal clocks were shifted later in the day tended to have more severe symptoms of the disorder. Additionally, the group with the eating disorder showed weaker daily rhythms in their physical activity, moving less vigorously during the day and resting less deeply at night compared to the control group. They also reported poorer diet quality and higher levels of a hormone called leptin, which is involved in appetite regulation.
Building on these observations, the researchers moved to a second phase to test if they could intentionally shift these biological clocks to see if it would improve symptoms. They selected participants who had binge eating disorder and divided them into two groups for a four-week trial. One group received a combination of morning bright light therapy and a small dose of melatonin taken at a specific time calculated for each individual. The bright light, delivered at an intensity of 10,000 lux, was designed to wake up the brain and push the internal clock earlier, while the melatonin was timed to reinforce this shift. The other group received a placebo version of the treatment, consisting of dim red light and a sugar pill, which served as a control. The goal was not to prove a cure, but to see if such a personalized approach was feasible and if it could actually move the body's clock.
The results of this intervention were mixed but offered important clues. The treatment did not successfully shift the timing of melatonin release in a way that was statistically different from the control group, meaning the researchers could not confirm that the protocol reliably advanced the internal clock for everyone. However, the study did uncover a significant relationship between a person's starting point and their response. Participants who began the study with a later internal clock showed a greater shift toward an earlier time and, notably, a greater reduction in the number of binge eating episodes they experienced each week. This suggests that the timing of the treatment might need to be tailored to the individual's specific biological state to be effective.
While the intervention did not produce a uniform shift in the body clock, it did have other measurable effects. The group receiving the bright light and melatonin maintained their daily activity rhythms better than the control group, who saw a decline in the strength of their movement patterns over the four weeks. The treatment group also reported an increase in their ability to restrain their eating choices and showed a rise in healthy fatty acids in their blood, alongside a trend toward lower insulin levels. The treatment was well-tolerated, with only minor side effects like headaches or vivid dreams reported. Ultimately, the study supports the idea that the circadian system plays a role in binge eating disorder, particularly for those whose internal clocks are shifted later. It demonstrates that a personalized approach to adjusting these rhythms is possible and safe, though the methods used here require further refinement to become a standard treatment. The findings highlight that for some individuals, the key to managing the disorder may lie in realigning the body's natural timing with the day and night cycle.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.